![Robert Goeltz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Goeltz
Director of Finance/CFO at
ARCUS BIOSCIENCES, INC.
Net worth: 2 M $ as of 2026-05-30
Profile
Robert C.
Goeltz is currently Chief Financial Officer at Arcus Biosciences, Inc. since 2023.
Formerly, Mr. Goeltz was Chief Financial Officer at Unity Biotechnology, Inc. from 2017 to 2020, Chief Financial Officer & Senior Vice President at CytomX Therapeutics, Inc. from 2015 to 2017, Chief Financial Officer at Onyx Pharmaceuticals, Inc. from 2013 to 2015, and Finance Director at Tularik, Inc. from 2002 to 2004.
Education includes undergraduate studies at Goizueta Business School-Emory and an MBA from UCLA Anderson School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-10 | 84,161 ( 0.07% ) | 2 M $ | 2026-05-30 |
Robert Goeltz active positions
| Companies | Position | Start |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director of Finance/CFO | 2020-07-31 |
Former positions of Robert Goeltz
| Companies | Position | End |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Director of Finance/CFO | 2020-07-31 |
| CYTOMX THERAPEUTICS, INC. | Director of Finance/CFO | 2017-05-14 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Director of Finance/CFO | 2015-04-30 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Director of Finance/CFO | 2004-07-31 |
Training of Robert Goeltz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
45
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Goizueta Business School-Emory
 Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
- Stock Market
- Insiders
- Robert Goeltz
